Ex-pharmacy exec acquitted of murder in meningitis outbreak

Ex-pharmacy exec acquitted of murder in meningitis outbreak

Ex-pharmacy exec acquitted of murder in meningitis outbreak (3/23/17)

BOSTON - The co-founder of a Massachusetts pharmacy has been acquitted of causing the deaths of 25 people but convicted of other racketeering charges in a nationwide meningitis outbreak in 2012.

Barry Cadden was charged with 25 counts of second-degree murder, conspiracy and other charges under the federal racketeering law. Overall, the outbreak killed 64 people and sickened 700 others in 20 states, including dozens in New Jersey.

The jury on Wednesday found that he wasn't responsible for the deaths. But they found him guilty of racketeering, conspiracy and mail fraud charges.

The fungal meningitis outbreak was traced to contaminated steroid injections manufactured by the New England Compounding Center in Framingham.

Prosecutors said Cadden ran the center in an "extraordinarily dangerous" way by skirting industry regulations on sterility and cleanliness in an effort to push production and make more money.

The Associated Press wire services helped contribute to this report.

advertisement | advertise on News 12

Trending Video

Investigators say Quadeer Nelson and Kevin McKenzie distributed 1 2 arrested for allegedly selling synthetic marijuana that sickened dozens
VIDEO: Amazon announces new NJ centers 2 VIDEO: Amazon announces new NJ centers
3 Police investigating overnight shooting in Paterson
4 Neighborhood Brief for April 23
Manta rays, dragons, octopuses and more littered the 5 Kite festival kicks off in Long Branch

advertisement | advertise on News 12

More News

FILE - In this March 16, 2017, file Ex-pharmacy exec convicted in deadly meningitis outbreak

The former head of a Massachusetts pharmacy has been convicted of racketeering in a meningitis

Sorry to interrupt...

Your first 5 are free

Access to News12 is free for Optimum, Comcast®, Time Warner® and Service Electric℠ video customers.

Please enjoy 5 complimentary views to articles, photos, and videos during the next 30 days.

LOGIN SUBSCRIBE